Patients with 3 or more adverse pregnancy outcomes had lower odds of postpartum contraceptive use in a PRAMS analysis of 222,412 individuals.
|Articles|September 6, 2011
Poll: Do You Routinely Use Compression Devices With C-section Patients?
Author(s)OBGYN.net Staff
ACOG has recently released “Thromboembolism in Pregnancy” in the September 2011 issue of 'Obstetrics & Gynecology' to guide clinicians in the prevention, management and treatment of blood clots during pregnancy.
Advertisement
ACOG has recently released “
Advertisement
Related to this article
Risk factors cast a wide net in preeclampsia prediction, but biomarkers could add precision, according to Dallas Reed, MD.
This FAQ summarizes a Special Report discussion on testosterone pellet therapy in women and advice for hesitant prescribers.
This FAQ summarizes a Special Report discussion on off-label testosterone dosing, application, cost, and lab monitoring in women.
This FAQ summarizes a Special Report discussion on how two experts decide who is a candidate for testosterone therapy in women, from symptoms and context to hormone state vs age.
This FAQ summarizes a Special Report discussion of what the evidence does and does not establish about testosterone therapy in women.
Real-world data show maternal RSVpreF vaccination was 82% effective against infant RSV LRTI hospitalization through 3 months.
Peter Hsin, BS, discusses a meta-analysis linking perioperative ketamine to lower early postpartum depressive symptoms after cesarean delivery.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
How estrogen-centered menopause care sidelined testosterone in women
2
Testosterone for women: Global consensus and physiologic dosing
3
What biomarker-guided preeclampsia care could look like
4
Testosterone physiology in women and the long road to approval
5